Gene expression profiling of prostate tissue identifies chromatin regulation as a potential link between obesity and lethal prostate cancer

Obese men are at higher risk of advanced prostate cancer and cancer‐specific mortality; however, the biology underlying this association remains unclear. This study examined gene expression profiles of prostate tissue to identify biological processes differentially expressed by obesity status and lethal prostate cancer.

[1]  Gretchen Hermann,et al.  Transcriptome evaluation of the relation between body mass index and prostate cancer outcomes , 2017, Cancer.

[2]  J. Yu,et al.  Interplay between epigenetics and metabolism in oncogenesis: mechanisms and therapeutic approaches , 2017, Oncogene.

[3]  L. Waldron,et al.  Comparing Platforms for Messenger RNA Expression Profiling of Archival Formalin-Fixed, Paraffin-Embedded Tissues. , 2015, The Journal of molecular diagnostics : JMD.

[4]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[5]  M. Loda,et al.  Role of diet in prostate cancer: the epigenetic link , 2014, Oncogene.

[6]  Peter Kraft,et al.  Association of Prostate Cancer Risk Variants with Gene Expression in Normal and Tumor Tissue , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[7]  J. Morrison,et al.  Epigenetics and human obesity , 2014, International Journal of Obesity.

[8]  Jennifer R. Rider,et al.  Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERG. , 2013, Journal of the National Cancer Institute.

[9]  Andrew P. Feinberg,et al.  Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host , 2013, Nature Reviews Cancer.

[10]  Martin J. Aryee,et al.  DNA Methylation Alterations Exhibit Intraindividual Stability and Interindividual Heterogeneity in Prostate Cancer Metastases , 2013, Science Translational Medicine.

[11]  Dario Strbenac,et al.  Regional activation of the cancer genome by long-range epigenetic remodeling. , 2013, Cancer cell.

[12]  J. Manson,et al.  Multivitamins in the prevention of cancer in men: the Physicians' Health Study II randomized controlled trial. , 2012, JAMA.

[13]  P. Hu,et al.  Obesity and prostate cancer: gene expression signature of human periprostatic adipose tissue , 2012, BMC Medicine.

[14]  A. Wolk,et al.  Body mass index and incidence of localized and advanced prostate cancer--a dose-response meta-analysis of prospective studies. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[15]  S. Freedland,et al.  Influence of obesity on the incidence and treatment of genitourinary malignancies. , 2011, Urologic oncology.

[16]  Hua Li,et al.  Prostate cancer gene expression signature of patients with high body mass index , 2010, Prostate Cancer and Prostatic Diseases.

[17]  Donna Spiegelman,et al.  American Journal of Epidemiology Practice of Epidemiology Comparison of Dual-energy X-ray Absorptiometric and Anthropometric Measures of Adiposity in Relation to Adiposity-related Biologic Factors , 2022 .

[18]  Gary D Bader,et al.  Enrichment Map: A Network-Based Method for Gene-Set Enrichment Visualization and Interpretation , 2010, PloS one.

[19]  N. Berger,et al.  Energy balance, host-related factors, and cancer progression. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  M. Stampfer,et al.  Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. , 2008, The Lancet. Oncology.

[21]  W. Weichert,et al.  Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy , 2008, British Journal of Cancer.

[22]  Yan Liu,et al.  Risk factors for prostate cancer incidence and progression in the health professionals follow‐up study , 2007, International journal of cancer.

[23]  C. Allis,et al.  Chromatin remodeling and cancer, Part I: Covalent histone modifications. , 2007, Trends in molecular medicine.

[24]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Horvath,et al.  Global histone modification patterns predict risk of prostate cancer recurrence , 2005, Nature.

[26]  E. Calle,et al.  Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms , 2004, Nature Reviews Cancer.

[27]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[28]  T. Speed,et al.  Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.

[29]  J. Manson,et al.  Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. , 1996, The New England journal of medicine.

[30]  E. Rimm,et al.  Validity of Self‐Reported Waist and Hip Circumferences in Men and Women , 1990, Epidemiology.